Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that currently has
reached epidemic proportions among elderly populations around the world. In China …

Alzheimer's disease (AD) is a common neurodegenerative brain disorder that causes
cellular response alterations, such as impaired cholinergic mechanism, amyloid-beta (Aβ) …

Alzheimer's disease (AD) has pathological hallmarks including amyloid beta (Aβ) plaque
formation. Currently approved single-target drugs cannot effectively ameliorate AD …

Alzheimer's disease (AD) is clinically characterized as memory deficits, altered behavior and
impaired cognitive functions. The most important risk factor for AD is aging and mounting …

Alzheimer's disease (AD) is one of the main healthcare challenges of the twenty-first century,
not only affecting millions of people's quality of life but also increasing the burden on the …

Introduction: Alzheimer's disease (AD) is a progressive, neurodegenerative disease that
severely affects individuals' cognitive abilities, memory, and quality of life. It affects the …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder and is the most common
cause of progressive dementia in aging. Research on AD therapy has been partly …

Alzheimer's disease is the major cause of dementia worldwide. The number of patients
suffering from dementia continue to rise reaching pandemic levels. Alzheimer's disease is …

Alzheimer's disease is an age-related, complex neurodegenerative disorder characterized
by loss of memory and impairment of multiple cognitive functions. Several factors contribute …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized clinically by
progressive memory deficits, impaired cognitive function, and altered and inappropriate …